ACQUIRED · 2024
Who Acquired Vantive (Baxter Kidney Care Segment)?
The Carlyle Group · $3.80B
The acquisition
Vantive (Baxter Kidney Care Segment) (Deerfield, IL) was acquired by The Carlyle Group in 2024 for $3.80B. Baxter's kidney care division including dialysis, organ support, and acute renal therapy portfolios. at 0.85× revenue.
Vantive (Baxter Kidney Care Segment) at time of acquisition
Revenue
$4450.0M
Deal value
$3.80B
Similar medical practice specialty acquisitions
- Consulting Cardiologists · acquired by Hartford HealthCare in 2026 · $3.0M
- EyeSouth Partners' Retina Business · acquired by Cencora, Inc. in 2026 · $1.10B
- OneOncology · acquired by Cencora, Inc. in 2025 · $7.40B
- OrthoAlliance · acquired by Optum / SCA Health in 2025 · $1.40B
- OrthoNY · acquired by Zenyth Partners / Evolve Orthopedic Partners in 2025 · $110.0M
Run a valuation for a similar medical practice specialty business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical practice specialty calculator →More on medical practice specialty valuations
- Medical Practice Specialty valuation calculator· head-term variant
- Medical Practice Specialty median multiples· real-deal benchmarks
- How to value a medical practice specialty· long-form guide
Sourced from Baxter Press Release. Primary source. Full deal page.
Citation: ExitValue.ai. (2024). Vantive (Baxter Kidney Care Segment) acquired by The Carlyle Group. https://exitvalue.ai/acquired/vantive-baxter-kidney-care-segment